Peginterferon alfa-2b
Peginterferon alfa-2b (PegIFN a-2b) is an immunomodulator. Peginterferon alfa-2b is a recombinant alfa-2b interferon covalently linked PEG. Peginterferon alfa-2b in decreasing viral DNA in HIV. Peginterferon alfa-2b can be used in research of melanoma and hepatitis C[1][2].
Product Specifications
CAS Number
[215647-85-1]
Product Name Alternative
PegIFN a-2b; Sch 54031; Sylatron; ViraferonPeg
UNSPSC
12352203
Hazard Statement
H360, H370
Target
HCV; HIV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Inflammation/Immunology
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Peginterferonalfa-2b]
Precautions
H360, H370
References & Citations
[1]Torres HA, et, al. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol. 2007 Jun;102 (6) :1334-5.|[2]Bruix J, et, al. Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C. Gastroenterology. 2011 Jun;140 (7) :1990-9.
Shipping Conditions
Room Temperature
Storage Conditions
Store at 4°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
